Origins, biology, and diseases of tissue macrophages
Tissue-resident macrophages are present in most tissues with developmental, self-renewal,
or functional attributes that do not easily fit into a textbook picture of a plastic and …
or functional attributes that do not easily fit into a textbook picture of a plastic and …
Histiocytosis and neoplasms of macrophage-dendritic cell lineages: multimodality imaging with emphasis on PET/CT
KN Huynh, BD Nguyen - Radiographics, 2021 - pubs.rsna.org
Histiocytosis is a rare inflammatory process characterized by pathologic infiltration and
accumulation of cells derived from the monocytic lineage in normal tissue. It encompasses …
accumulation of cells derived from the monocytic lineage in normal tissue. It encompasses …
Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation
PG Kemps, KM Hebeda, ST Pals… - The Journal of …, 2021 - Wiley Online Library
Histiocytic disorders are a spectrum of rare diseases characterised by the accumulation of
macrophage‐, dendritic cell‐, or monocyte‐differentiated cells in various tissues and organs …
macrophage‐, dendritic cell‐, or monocyte‐differentiated cells in various tissues and organs …
Mimickers of large vessel giant cell arteritis
Giant cell arteritis (GCA) is a large-vessel granulomatous vasculitis occurring in patients
over 50-year-old. Diagnosis can be challenging because there is no specific biological test …
over 50-year-old. Diagnosis can be challenging because there is no specific biological test …
Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective
M Kanakis, P Petrou, G Lourida, I Georgalas - Survey of Ophthalmology, 2022 - Elsevier
Erdheim–Chester disease (ECD) is a rare clonal histiocytic neoplasm with less than 1200
documented cases to date. The disease is life-threatening and difficult to recognize …
documented cases to date. The disease is life-threatening and difficult to recognize …
Molecular mutations in histiocytosis: a comprehensive survey of genetic alterations
Histiocytosis represents a group of uncommon disorders characterized by the abnormal
accumulation of specialized immune cells, such as macrophages, dendritic cells, or …
accumulation of specialized immune cells, such as macrophages, dendritic cells, or …
[HTML][HTML] Vemurafenib in the treatment of Erdheim Chester disease: a systematic review
SN Aziz, L Proano, C Cruz, MG Tenemaza, G Monteros… - Cureus, 2022 - ncbi.nlm.nih.gov
Erdheim Chester disease (ECD) is a type of histiocytosis characterized by a variable clinical
presentation. The treatment of ECD is complex and mainly unknown. We aim to conduct a …
presentation. The treatment of ECD is complex and mainly unknown. We aim to conduct a …
[HTML][HTML] Advances in Understanding and Management of Erdheim-Chester Disease
AM Kulkarni, PKR Gayam, JM Aranjani - Life Sciences, 2024 - Elsevier
Abstract Erdheim Chester Disease (ECD) is a rare histiocytic disorder marked by infiltration
of organs with CD68+ histiocytes. ECD stems from mutations of BRAF and MAP2K1 in …
of organs with CD68+ histiocytes. ECD stems from mutations of BRAF and MAP2K1 in …
Skeletal involvement in Erdheim-Chester disease: Multimodality imaging features and association with the BRAFV600E mutation
Objective The aim of this study was to characterize the distribution of skeletal involvement in
Erdheim-Chester disease (ECD) by using radiography, computed tomography (CT), 18 F …
Erdheim-Chester disease (ECD) by using radiography, computed tomography (CT), 18 F …
Cyclin D1 expression and molecular genetic findings in periocular histiocytoses and neoplasms of macrophage-dendritic cell lineage
PURPOSE Frequent activating mutations in the mitogen-activated protein kinase (MAPK)
pathway genes have been identified in histiocytoses. MAPK signaling consistently …
pathway genes have been identified in histiocytoses. MAPK signaling consistently …